Immunotherapy with NK cells: recent developments in gene modification open up new avenues
Lisa Marie Reindl(Goethe University Frankfurt), Evelyn Ullrich(Goethe University Frankfurt), Nawid Albinger(Goethe University Frankfurt), Tobias Bexte(Goethe University Frankfurt), Jessica Hartmann(Paul Ehrlich Institut), Stephan Müller(Goethe University Frankfurt)
Cited by 41
Related Papers
High Cytotoxic Efficiency of Lentivirally and Alpharetrovirally Engineered CD19-Specific Chimeric Antigen Receptor Natural Killer Cells Against Acute Lymphoblastic Leukemia
|Frontiers in Immunology|2020|111
CRISPR-Cas9 based gene editing of the immune checkpoint NKG2A enhances NK cell mediated cytotoxicity against multiple myeloma
|OncoImmunology|2022|77
CRISPR/Cas9 editing of NKG2A improves the efficacy of primary CD33-directed chimeric antigen receptor natural killer cells
|Nature Communications|2024|71